Results 271 to 280 of about 1,913,070 (304)
Some of the next articles are maybe not open access.
Obinutuzumab in Chronic Lymphocytic Leukemia
Future Oncology, 2015Obinutuzumab is the second next-generation monoclonal anti-CD20 antibody (after ofatumumab) to enter clinical practice in chronic lymphocytic leukemia. Its superiority in association with chlorambucil as compared with chlorambucil alone has led to its approval as a first-line treatment for chronic lymphocytic leukemia, for patients who are not ...
openaire +2 more sources
The American Journal of the Medical Sciences, 1994
P B, Caguioa, S, Tansan, R P, McCaffrey
openaire +2 more sources
P B, Caguioa, S, Tansan, R P, McCaffrey
openaire +2 more sources
Erythropoietin and chronic lymphocytic leukemia.
Reviews in clinical and experimental hematology, 2002Anemia is a frequent clinical feature with adverse prognostic effects in patients with chronic lymphocytic leukemia (CLL). It may complicate CLL at any time during the course of the disease. Different factors concur to the occurrence of anemia in CLL, as in other lymphoproliferative diseases: leukemic bone marrow infiltration, the myelosuppressive ...
MAURO, Francesca Romana +2 more
openaire +3 more sources
Zanubrutinib in Chronic Lymphocytic Leukemia
New England Journal of Medicine, 2023Yang, Liang, Robert P, Gale
openaire +3 more sources
Acalabrutinib in chronic lymphocytic leukemia
Expert Opinion on Pharmacotherapy, 2023Martino, Enrica Antonia +10 more
openaire +2 more sources